Literature DB >> 18435704

Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation.

Seung-Shick Shin1, Jin Namkoong, Brian A Wall, Ryan Gleason, Hwa Jin Lee, Suzie Chen.   

Abstract

Previously, we reported a transgenic mouse line, TG-3, that develops spontaneous melanoma with 100% penetrance. We demonstrated that ectopic expression of Grm1 in melanocytes was sufficient to induce melanoma in vivo. In this present study, the transforming properties of Grm1 in two cultured immortalized melanocytes were investigated. We showed that, in contrast to parental melanocytes, these Grm1-clones have lost their requirement of TPA supplement for proliferation and have acquired the ability to form colonies in semi-solid medium. Xenografts of these cells formed robust tumors in both immunodeficient nude and syngeneic mice with a short latency (3-5 days). The malignancy of these cells was demonstrated by angiogenesis and invasion to the muscle and the intestine. The requirement of Grm1 expression for the maintenance of transformation was demonstrated by an inducible siRNA system. Induction of expression of siRNA for Grm1 reduced the number of proliferating/viable cells in vitro and suppressed in vivo xenografted tumor growth in comparison with control. Taken together, these results showed that expression of exogeneously introduced Grm1 is sufficient to induce full transformation of immortalized melanocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435704      PMCID: PMC2854004          DOI: 10.1111/j.1755-148X.2008.00452.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  38 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Cloning of novel splice variants of mouse mGluR1.

Authors:  H Zhu; K Ryan; S Chen
Journal:  Brain Res Mol Brain Res       Date:  1999-11-10

Review 3.  Activated ras. Yet another player in melanoma?

Authors:  M Herlyn; K Satyamoorthy
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.

Authors:  S I Shin; V H Freedman; R Risser; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

Review 5.  Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.

Authors:  E Hermans; R A Challiss
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

6.  Development of heritable melanoma in transgenic mice.

Authors:  H Zhu; K Reuhl; X Zhang; R Botha; K Ryan; J Wei; S Chen
Journal:  J Invest Dermatol       Date:  1998-03       Impact factor: 8.551

7.  Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins.

Authors:  J D Owen; R Strieter; M Burdick; H Haghnegahdar; L Nanney; R Shattuck-Brandt; A Richmond
Journal:  Int J Cancer       Date:  1997-09-26       Impact factor: 7.396

Review 8.  The regulation of normal melanocyte proliferation.

Authors:  R Halaban
Journal:  Pigment Cell Res       Date:  2000-02

Review 9.  The metabotropic glutamate receptors: structure and functions.

Authors:  J P Pin; R Duvoisin
Journal:  Neuropharmacology       Date:  1995-01       Impact factor: 5.250

10.  Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment.

Authors:  G P Dotto; G Moellmann; S Ghosh; M Edwards; R Halaban
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  41 in total

1.  mGlu Receptors and Cancerous Growth.

Authors:  Jessica Teh; Suzie Chen
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2011-10-25

Review 2.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

Review 3.  Molecular pathways: dysregulated glutamatergic signaling pathways in cancer.

Authors:  Todd D Prickett; Yardena Samuels
Journal:  Clin Cancer Res       Date:  2012-05-30       Impact factor: 12.531

4.  The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.

Authors:  Maithao N Le; Joseph L-K Chan; Stephen A Rosenberg; Adam S Nabatian; Kim T Merrigan; Karine A Cohen-Solal; James S Goydos
Journal:  J Invest Dermatol       Date:  2010-05-27       Impact factor: 8.551

5.  Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

Authors:  Xiaomu Wei; Vijay Walia; Jimmy C Lin; Jamie K Teer; Todd D Prickett; Jared Gartner; Sean Davis; Katherine Stemke-Hale; Michael A Davies; Jeffrey E Gershenwald; William Robinson; Steven Robinson; Steven A Rosenberg; Yardena Samuels
Journal:  Nat Genet       Date:  2011-04-15       Impact factor: 38.330

Review 6.  PET and SPECT imaging of melanoma: the state of the art.

Authors:  Weijun Wei; Emily B Ehlerding; Xiaoli Lan; Quanyong Luo; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-30       Impact factor: 9.236

7.  Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.

Authors:  Jessica L F Teh; Raj Shah; Stephanie La Cava; Sonia C Dolfi; Madhura S Mehta; Sameera Kongara; Sandy Price; Shridar Ganesan; Kenneth R Reuhl; Kim M Hirshfield; Vassiliki Karantza; Suzie Chen
Journal:  Breast Cancer Res Treat       Date:  2015-04-10       Impact factor: 4.872

8.  Metabotropic glutamate receptor 6 signaling enhances TRPM1 calcium channel function and increases melanin content in human melanocytes.

Authors:  Sulochana Devi; Yogananda Markandeya; Nityanand Maddodi; Anuradha Dhingra; Noga Vardi; Ravi C Balijepalli; Vijayasaradhi Setaluri
Journal:  Pigment Cell Melanoma Res       Date:  2013-03-27       Impact factor: 4.693

9.  Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells.

Authors:  Shahriar Koochekpour; Sunipa Majumdar; Gissou Azabdaftari; Kristopher Attwood; Ray Scioneaux; Dhatchayini Subramani; Charles Manhardt; Giovanni D Lorusso; Stacey S Willard; Hillary Thompson; Mojgan Shourideh; Katayoon Rezaei; Oliver Sartor; James L Mohler; Robert L Vessella
Journal:  Clin Cancer Res       Date:  2012-10-16       Impact factor: 12.531

10.  AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1).

Authors:  Seung-Shick Shin; Brian A Wall; James S Goydos; Suzie Chen
Journal:  Pigment Cell Melanoma Res       Date:  2009-10-20       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.